首页|lnc85通过调节CDC42的表达促进肝癌细胞增殖

lnc85通过调节CDC42的表达促进肝癌细胞增殖

扫码查看
目的:探讨长链非编码RNA RP11-85G21.1(lnc85)对肝癌细胞增殖的作用及可能机制.方法:RNA全转录组测序结合实时荧光定量PCR(RT-qPCR)筛选验证肝癌中差异高表达的lnc85;利用lnc85过表达/空载慢病毒感染细胞,构建lnc85过表达肝癌细胞株(OE)和对照细胞(control);RNA下拉实验(RNA pull-down)联合质谱筛选lnc85互作蛋白并进行蛋白免疫印迹(western blotting)验证;MTT实验、细胞克隆形成实验分析lnc85过表达对细胞增殖的影响;生物信息学分析lnc85互作蛋白表达水平及对生存的影响.结果:RNA全转录组测序发现,与对照相比,lnc85在肝癌患者血浆外泌体中明显高表达(P<0.001),RT-qPCR验证lnc85在3种肝癌细胞中显著升高(P<0.01,P<0.001);RNA pull-down联合质谱分析发现CDC42为lnc85的互作蛋白,RT-qPCR证实CDC42水平在肝癌细胞显著升高(P<0.001);且lnc85过表达的肝癌细胞中,CDC42蛋白水平显著上调(P<0.001),细胞增殖能力显著增强(P<0.01);生物信息学分析发现,肝癌患者CDC42的表达水平显著高于健康对照(P<0.001),并随着肿瘤等级的增高而增高;高表达CDC42的肝癌患者预后不良(P<0.001).结论:lnc85在肝癌中高表达,可能通过靶向调节CDC42的表达促进肝癌细胞的增殖.
The lnc85 promoting the proliferation of hepatoma cells by regulating the expression of CDC42
Objective:To investigate the effect of long non-coding RNA RP11-85G21.1(lnc85)on the prolifera-tion of hepatoma cells and its possible mechanism.Methods:The whole transcriptome RNA sequencing com-bined with reverse transcription-quantitative PCR(RT-qPCR)was used to screen and verify lnc85 with differen-tially high expression in liver cancer.The lnc85 overexpressing liver cancer cell line(OE)and control cells(con-trol)were constructed by infecting cells with lnc85 overexpression/empty vector lentivirus.The interacting pro-teins of lnc85 were screened by RNA pull-down assay combined with mass spectrometry and verified by western blotting.MTT assay and cell clone formation assay were used to analyze the effect of cell proliferation after lnc85 overexpression.Bioinformatics analysis was used to analyze the expression level of lnc85 interacting pro-tein and its effect on survival of patients with liver cancer.Results:The results of the whole transcriptome RNA sequencing showed that lnc85 was significantly highly expressed in the plasma exosomes of patients with liver cancer compared with the control group(P<0.001),and RT-qPCR verified that lnc85 was significantly increased in the three hepatoma cells(P<0.01,P<0.001).RNA pull-down combined with mass spectrometry showed that cell division cycle 42(CDC42)was an interacting protein of lnc85,and RT-qPCR confirmed that CDC42 level was significantly increased in hepatoma cells(P<0.001).In hepatoma cells with lnc85 overexpression,CDC42 protein level was significantly up-regulated(P<0.001)and cell proliferation ability was significantly enhanced(P<0.01).Bioinformatics analysis showed that the expression level of CDC42 in patients with liver cancer was significantly higher than that in healthy controls(P<0.001),and the expressing level of CDC42 showed an in-creasing trend as the increase of tumor grade.High CDC42 expression was associated with poor prognosis in pa-tients with liver cancer(P<0.001).Conclusion:The lnc85 is highly expressed in liver cancer and may promote the proliferation of hepatoma cells by targeting and regulating CDC42 expression.

liver cancerlong non-coding RNA RP11-85G21.1cell division cycle 42RNA pull-down assaycell proliferation

宋振宇、杨丽超、廖舟翔、张起、温莎、黄雪静、何敏

展开 >

广西医科大学公共卫生学院,南宁 530021

广西医科大学实验动物中心,南宁 530021

区域性高发肿瘤早期防治研究重点实验室,南宁 530021

肝癌 长链非编码RNA RP11-85G21.1 细胞分裂周期蛋白42 RNA下拉实验 细胞增殖

国家自然科学基金青年基金广西自然科学基金青年基金

320008652021GXNSFBA220014

2024

广西医科大学学报
广西医科大学

广西医科大学学报

CSTPCD
影响因子:0.788
ISSN:1005-930X
年,卷(期):2024.41(2)
  • 27